<DOC>
	<DOCNO>NCT03032029</DOCNO>
	<brief_summary>The European ASV Registry ( short name ) investigate use Adaptive Servo-Ventilation non-heart failure condition . The purpose examine effect ASV quality life , daytime symptom sleep , describe usage pattern ASV regard patient characteristic document adverse event related therapy therapy safety analysis . A pilot phase enrol least 200 patient test feasibility registry . After pilot phase complete intermediate data analysis perform , registry expand several country across Europe goal enrol 1000 patient period 5 year .</brief_summary>
	<brief_title>European Registry Adaptive Servo-Ventilation ( ASV ) Sleep-Disordered Breathing</brief_title>
	<detailed_description>The collection data perform course clinical routine . In regular clinical practice , first control visit ( i.e . Follow-up number one ) occur first 6 month . Further follow-up visit indicate patient reporting problem course therapy . We recommend FU visit least year ( first routine FU visit ) . Each patient include 6 month , total duration phase 1 registry .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Sleep Apnea , Central</mesh_term>
	<criteria>Patients â‰¥18 year Age Prescription ResMed AirCurve 10 CS PaceWave S9 AutoSet CS PaceWave treatment ASV Naive ASV Treatment Able fully understand information data protection provide write informed consent Heart Failure ( HF ) Left Ventricular Ejection Fraction ( LVEF ) &lt; 45 % CSA &gt; 50 % central apnea apneas</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>